Ambulatory quality indicators to prevent infection in sickle cell disease

American Journal of Hematology

Volumn 89, Issue 3, 2014, Pages 256-260

  Beverung, Lauren M ^a,b   Brousseau, David ^a,c   Hoffmann, Raymond G ^a,d   Yan, Ke ^a,d   Panepinto, Julie A ^a,b  

^a Children's Hospital of Wisconsin   (United States)

^b Section of Pediatric Hematology Oncology Bone Marrow Transplant   (United States)

^c Section of Pediatric Emergency Medicine   (United States)

^d Department of Pediatrics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; AMBULATORY CARE; ARTICLE; BACTERIAL INFECTION; CHILD; COHORT ANALYSIS; FEMALE; HEALTH CARE QUALITY; HUMAN; IMMUNIZATION; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICATION COMPLIANCE; OUTPATIENT CARE; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SICKLE CELL ANEMIA; YOUNG ADULT;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; ANTIBIOTIC PROPHYLAXIS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFLUENZA VACCINES; MEDICAID; PATIENT COMPLIANCE; PENICILLINS; PNEUMOCOCCAL VACCINES; QUALITY INDICATORS, HEALTH CARE; UNITED STATES; VACCINATION; YOUNG ADULT;

EID: 84896894640     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23627     Document Type: Article

References (25)

1. Brousseau DC, Panepinto JA, Nimmer M, et al. The number of people with sickle-cell disease in the united states: National and state estimates. Am J Hematol 2010;85:77-78.
2. Panepinto JA, Pajewski NM, Foerster LM, et al. Impact of family income and sickle cell disease on the health-related quality of life of children. Qual Life Res 2009;18:5-13.
3. Panepinto JA, Bonner M. Health-related quality of life in sickle cell disease: Past, present, and future. Pediatr Blood Cancer 2012;59:377-385.
4. Wang CJ, Kavanagh PL, Little AA, et al. Quality-of-care indicators for children with sickle cell disease. Pediatrics 2011;128:484-493.
5. Shankar SM, Arbogast PG, Mitchel E, et al. Medical care utilization and mortality in sickle cell disease: A population-based study. Am J Hematol 2005;80:262-270.
6. Amendah DD, Mvundura M, Kavanagh PL, et al. Sickle cell disease-related pediatric medical expenditures in the U.S. Am J Prev Med 2010;38:S550-S556.
7. Hemker BG, Brousseau DC, Yan K, et al. When children with sickle-cell disease become adults: Lack of outpatient care leads to increased use of the emergency department. Am J Hematol 2011;86:863-865.
8. Leschke J, Panepinto JA, Nimmer M, et al. Outpatient follow-up and rehospitalizations for sickle cell disease patients. Pediatr Blood Cancer 2012;58:406-409.
9. CDC. Persons for whom annual vaccination is recommended: Influenza prevention and control recommendations. Available at: http://www.Cdc.Gov/flu/professionals/acip/persons.Htm. November 30, 2012.
10. Candrilli SD, O'Brien SH, Ware RE, et al. Hydroxyurea adherence and associated outcomes among medicaid enrollees with sickle cell disease. Am J Hematol 2011;86:273-277.
11. Andrade SE, Kahler KH, Frech F, et al. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 2006;15:565-574.
12. Ritho J, Liu H, Hartzema AG, et al. Hydroxyurea use in patients with sickle cell disease in a medicaid population. Am J Hematol 2011;86:888-890.
13. Jordan LB, Vekeman F, Sengupta A, et al. Persistence and compliance of deferoxamine versus deferasirox in medicaid patients with sickle-cell disease. J Clin Pharm Ther 2012;37:173-181.
14. Williams WW, Lu PJ, Lindley MC, et al. Influenza vaccination coverage among adults-National health interview survey, united states, 2008-09 influenza season. CDC Morbidity and Mortality Weekly Report 2012;61(Suppl):65.
15. Fu LY, Cowan N, McLaren R, et al. Spatial accessibility to providers and vaccination compliance among children with medicaid. Pediatrics 2009;124:1579-1586.
16. Howard-Jones M, Randall L, Bailey-Squire B, et al. An audit of immunisation status of sickle cell patients in Coventry, UK. J Clin Pathol 2009;62:42-45.
17. Warren MD, Arbogast PG, Dudley JA, et al. Adherence to prophylactic antibiotic guidelines among medicaid infants with sickle cell disease. Arch Pediat Adol Med 2010;164:298-299.
18. Patel NG, Lindsey T, Strunk RC, et al. Prevalence of daily medication adherence among children with sickle cell disease: A 1-year retrospective cohort analysis. Pediatr Blood Cancer 2010;55:554-556.
19. Payne AB, Link-Gelles R, Azonobi I, et al. Invasive pneumococcal disease among children with and without sickle cell disease in the united states, 1998-2009. Pediatr Infect Dis J 2013;ePub ahead of print.
20. Marcum ZA, Sevick MA, Handler SM. Medication nonadherence: A diagnosable and treatable medical condition. JAMA 2013;309:2105-2106.
21. Rees S, Stevens L, Drayton J, et al. Improving inpatient pneumococcal and influenza vaccination rates. J Nurs Care Qual 2011;26:358-363.
22. Allred NJ, Wooten KG, Kong Y. The association of health insurance and continuous primary care in the medical home on vaccination coverage for 19- to 35-month-old children. Pediatrics 2007;119 S4-S11.
23. Raphael JL, Rattler TL, Kowalkowski MA, et al. The medical home experience among children with sickle cell disease. Pediatr Blood Cancer 2013;60:275-280.
24. Treadwell M, Telfair J, Gibson RW, et al. Transition from pediatric to adult care in sickle cell disease: Establishing evidence-based practice and directions for research. Am J Hematol 2011;86:116-120.
25. U.S. Census Bureau; American Community Survey, 2006-2010 5-year estimates; generated using American factfinder. Available at: http://factfinder2.Census.Gov. May 7, 2013.